XOMAP Q4 2023 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+23.4% YoY

Gross Profit

$2M98.6% margin

Operating Income

-$20M-1087.5% margin

Net Income

-$20M-1097.1% margin

EPS (Diluted)

$-1.87

QoQ Revenue Growth

+120.8%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$234M

Total Liabilities

$146M

Stockholders' Equity

$89M

Cash & Equivalents

$153M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+23.4%
Gross Profit	$2M	$1M	+24.0%
Operating Income	-$20M	-$6M	-221.0%
Net Income	-$20M	-$6M	-236.5%